![Paul Hastings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Hastings
Vorstandsvorsitzender bei
NKARTA, INC.
Vermögen: 1 Mio $ am 30.06.2026
Profil
Mr. Paul J.
Hastings is a Chairman at Specific Biologics, Inc., an Independent Director at enGene Therapeutics, Inc. and a Chief Executive Officer & Director at Nkarta, Inc. He is on the Board of Directors at enGene Therapeutics, Inc., Termeer Foundation, Nkarta, Inc., California Life Sciences Association, California Biomedical Innovation Alliance and Pacira Pharmaceuticals, Inc. (California).
Mr. Hastings was previously employed as a Chairman by Proteon Therapeutics, Inc., an Independent Director by Relypsa, Inc., a Chairman by Pacira Biosciences, Inc., a Chairman by Proteolix, Inc., a Chairman, President & Chief Executive Officer by OncoMed Pharmaceuticals, Inc., a President & Chief Executive Officer by QLT, Inc., a President & Chief Executive Officer by Axys Pharmaceuticals, Inc., a President by CHIRON Biopharmaceuticals, a President & Chief Executive Officer by LXR Biotechnology, Inc., a President-Worldwide Therapeutics by Genzyme Corp., a Chairman by Biotechnology Innovation Organization, a Principal by Hoffmann-La Roche, Inc., and a GM-European Division, VP-Sales & Marketing by Synergen, Inc. He also served on the board at ViaCyte, Inc., California Healthcare Institute, ViaCell, Inc., Arriva Pharmaceuticals, Inc., Cerimon Pharmaceuticals, Inc. and The Bay Area Bioscience Association.
He received his undergraduate degree from the University of Rhode Island.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NKARTA, INC. 0,55 % | 18.06.2026 | 390 247 ( 0,55 % ) | 1 Mio $ | 30.06.2026 |
| 16.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Paul Hastings
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Vorstandsvorsitzender | 01.02.2018 |
| ENGENE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 15.05.2024 |
Termeer Foundation
 Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of transformative, patient-centered healthcare treatments. The private company is based in Boston. The foundation fosters a diverse, inclusive community of first-time CEOs, entrepreneurs, academics, and STEM students through values-driven leadership programs emphasizing responsibility, passion, creativity, humility, and connectivity. Key offerings include the Termeer Fellows Program for early-stage biotech CEOs, the Termeer Scholars Program for academic researchers translating discoveries into innovations, and support for STEM students. The foundation provides mentorship, executive coaching, strategic networking, and grants to cultivate leadership and collaboration across the life sciences sector. The American company was founded by Alan E. Walts. | Gründer | 01.06.2023 |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Direktor/Vorstandsmitglied | - |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direktor/Vorstandsmitglied | 01.01.2013 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Direktor/Vorstandsmitglied | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Vorsitzender | 11.06.2025 |
Ehemalige bekannte Positionen von Paul Hastings
| Unternehmen | Position | Ende |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Vorsitzender | 28.01.2025 |
| ONCOMED PHARMACEUTICALS INC | Vorstandsvorsitzender | 01.01.2018 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Paul Hastings
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
LXR Biotechnology, Inc.
 LXR Biotechnology, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics to treat diseases | Health Technology |
Synergen, Inc.
 Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Health Technology |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
CHIRON Biopharmaceuticals | |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Commercial Services |
Termeer Foundation
Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of transformative, patient-centered healthcare treatments. The private company is based in Boston. The foundation fosters a diverse, inclusive community of first-time CEOs, entrepreneurs, academics, and STEM students through values-driven leadership programs emphasizing responsibility, passion, creativity, humility, and connectivity. Key offerings include the Termeer Fellows Program for early-stage biotech CEOs, the Termeer Scholars Program for academic researchers translating discoveries into innovations, and support for STEM students. The foundation provides mentorship, executive coaching, strategic networking, and grants to cultivate leadership and collaboration across the life sciences sector. The American company was founded by Alan E. Walts. | Consumer Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Wählen Sie MarketScreener 
